182 related articles for article (PubMed ID: 19157720)
1. Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors.
Kalinski T; Sel S; Kouznetsova I; Röpke M; Roessner A
Pathol Res Pract; 2009; 205(5):339-45. PubMed ID: 19157720
[TBL] [Abstract][Full Text] [Related]
2. [Angiogenesis in cartilage tumors].
Kalinski T; Roessner A
Pathologe; 2010 Oct; 31 Suppl 2():177-82. PubMed ID: 20661574
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of VEGF-A and angiopoietins in cartilage tumors and regulation by interleukin-1beta.
Kalinski T; Krueger S; Sel S; Werner K; Ropke M; Roessner A
Cancer; 2006 May; 106(9):2028-38. PubMed ID: 16565972
[TBL] [Abstract][Full Text] [Related]
5. Analysis of angiogenic factors and cyclooxygenase-2 expression in cartilaginous tumors- clinical and histological correlation.
Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
Clinics (Sao Paulo); 2011; 66(9):1591-6. PubMed ID: 22179165
[TBL] [Abstract][Full Text] [Related]
6. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
Aigner T; Unni CC; Bjornsson J; Kirchner T
Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of estrogen receptors in chondrosarcomas and enchondromas.
Grifone TJ; Haupt HM; Podolski V; Brooks JJ
Int J Surg Pathol; 2008 Jan; 16(1):31-7. PubMed ID: 18203781
[TBL] [Abstract][Full Text] [Related]
9. C-propeptides of procollagens I alpha 1 and II that differentially accumulate in enchondromas versus chondrosarcomas regulate tumor cell survival and migration.
Vincourt JB; Etienne S; Cottet J; Delaunay C; Malanda CB; Lionneton F; Sirveaux F; Netter P; Plénat F; Mainard D; Vignaud JM; Magdalou J
Cancer Res; 2010 Jun; 70(11):4739-48. PubMed ID: 20460531
[TBL] [Abstract][Full Text] [Related]
10. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
11. Vascular pattern in enchondroma and chondrosarcoma: clinical and immunohistologic study.
Cintra FF; Etchebehere M; Gonçalves JC; Cassone AE; Amstalden EM
Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):600-5. PubMed ID: 24897071
[TBL] [Abstract][Full Text] [Related]
12. PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors.
Amling M; Pösl M; Hentz MW; Priemel M; Delling G
Verh Dtsch Ges Pathol; 1998; 82():160-9. PubMed ID: 10095428
[TBL] [Abstract][Full Text] [Related]
13. Microvasculature and VEGF expression in cartilaginous tumors.
Ayala G; Liu C; Nicosia R; Horowitz S; Lackman R
Hum Pathol; 2000 Mar; 31(3):341-6. PubMed ID: 10746677
[TBL] [Abstract][Full Text] [Related]
14. Pathologic neovascularization in cartilage tumors.
McGough RL; Aswad BI; Terek RM
Clin Orthop Relat Res; 2002 Apr; (397):76-82. PubMed ID: 11953598
[TBL] [Abstract][Full Text] [Related]
15. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.
Welén K; Jennbacken K; Tesan T; Damber JE
Prostate Cancer Prostatic Dis; 2009; 12(1):41-6. PubMed ID: 18521102
[TBL] [Abstract][Full Text] [Related]
16. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations.
Kiuchi H; Tsujimura A; Takao T; Yamamoto K; Nakayama J; Miyagawa Y; Nonomura N; Takeyama M; Okuyama A
BJU Int; 2009 Sep; 104(6):826-31; discussion 831. PubMed ID: 19298410
[TBL] [Abstract][Full Text] [Related]
17. Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma.
Takeuchi A; Yamamoto Y; Tsuneyama K; Cheng C; Yonekura H; Watanabe T; Shimizu K; Tomita K; Yamamoto H; Tsuchiya H
Cancer; 2007 Jun; 109(12):2532-40. PubMed ID: 17497647
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
19. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
20. PAS inclusions, immunoreactive tenascin and proliferative activity in low-grade chondrosarcomas.
Ranty ML; Michot C; Le Pessot F; Hellot MF; Biga N; Dujardin FH; Simonet J; Billerey C; Metayer J
Pathol Res Pract; 2003; 199(1):29-34. PubMed ID: 12650515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
